Skip to main content
Company Info
News
Events & Presentations
Events Calendar
Presentations
Stock Information
Stock Info
Financial Information
Financial Results
SEC Filings
Governance
Governance Documents
Committee Composition
Management
Board of Directors
Resources
Investor Emails Alerts
Investor Contacts
RSS Feeds
Site Search
News
Company Info
News
Events & Presentations
Events Calendar
Presentations
Stock Information
Stock Info
Financial Information
Financial Results
SEC Filings
Governance
Governance Documents
Committee Composition
Management
Board of Directors
Resources
Investor Emails Alerts
Investor Contacts
RSS Feeds
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
11/29/2018
AgeX Therapeutics, Inc. to Present Keynote Address at Advanced Stem Cell & Regenerative Medicine 2018 Conference
11/29/2018
AgeX Therapeutics, Inc. Shares Commence Trading on the NYSE American
09/17/2018
BioTime Updates Timeline For Distribution Of AgeX Shares To BioTime Shareholders – Regulatory Approvals In-Process; New Record Date To Be Set Shortly
09/04/2018
BioTime Closes $43.2 Million AgeX Share Sale Transaction With Juvenescence
08/16/2018
AgeX Therapeutics Acquires Technology To Regulate Immune Tolerance – Technology Supports Company’s Strategy For Off-The-Shelf (Allogeneic) Cell-Based Regenerative Medicine Products Through The Use Of The HLA-G Gene
08/02/2018
BioTime To Receive $21.6 Million In Cash And $21.6 Million In A Convertible/Redeemable Note For 14.4 Million Shares Of AgeX Therapeutics. Creates Alignment Between AgeX Therapeutics And Juvenescence Limited To Potentially Become Leader In The Field Of Aging
07/11/2018
AgeX Therapeutics CEO Dr. Michael D. West To Present At Ending Age-Related Diseases: Investment Prospects & Advances In Research, July 12 In New York City
07/10/2018
BioTime Announces July 31, 2018 Record Date For The Distribution Of AgeX Therapeutics Shares
06/11/2018
Agex Therapeutics Closes On $5 Million Strategic Investment From Juvenescence
06/05/2018
Agex Therapeutics Appoints John F. Mauldin To Board Of Directors
05/17/2018
Agex Therapeutics Ceo Dr. Michael D. West To Deliver Keynote Address At World Advanced Therapies & Regenerative Medicine Congress, May 18 In London
05/02/2018
Agex Announces Nih Grant Award
03/01/2018
Agex Therapeutics Ceo Dr. Michael D. West To Present At Three Conferences In March 2018
01/18/2018
Agex Ceo Michael D. West To Present In Plenary Session At The World Stem Cell Summit On “Stem Cell Innovations That Will Change The World”
01/06/2018
Agex Therapeutics To Present At Biotech Showcase Annual Conference
01/02/2018
AgeX Therapeutics Identifies Genes Implicated In Tissue Regeneration And Cancer